This website uses cookies primarily for visitor analytics. Certain pages will ask you to fill in contact details to receive additional information. On these pages you have the option of having the site log your details for future visits. Indicating you want the site to remember your details will place a cookie on your device. To view our full cookie policy, please click here. You can also view it at any time by going to our Contact Us page.

Cellphone-sized device quickly detects the Ebola virus

29 April 2016

Scientists report in ACS’ journal Analytical Chemistry a handheld instrument that detects Ebola quickly and could be used in remote locations.

Scientists have developed a handheld device that can detect Ebola RNA in less than 40 minutes. (Credit: American Chemical Society)

The gold standard method for identifying the Ebola virus in a blood sample requires packaging samples in cooled containers and sending them to specialised laboratories, often far away from where patients live. Lab personnel use a method called reverse-transcription polymerase chain reaction, or RT-PCR, to check for the virus. The prolonged testing process delays detection, treatment and real-time monitoring of viral loads in body fluids that can harbor the virus even after it’s no longer detected in blood. To make reliable and fast Ebola detection more accessible, Pavel Neuzil and colleagues developed a cellphone-sized device, which they reported in a previous paper.

In their latest study, the researchers designed and tested the instrument, which could simultaneously perform four RT-PCRs that included two controls and two patient blood samples. Conventional tests require several hours to more than a day for results to come in. The new process took less than 37 minutes, and the amount of blood required was minute and could potentially come from just a finger prick. The device successfully detected the Ebola RNA. In addition to diagnosing the illness, the test also yielded information about how many RNA copies each sample contained. In addition to diagnosing the illness, they say that the tool could also potentially help health care workers track patients’ viral loads in semen, breast milk and eye fluids after recovery.

For more information visit the ACS website.


Print this page | E-mail this page